Skip to main content
. 2020 Dec 8;11(1):1350–1367. doi: 10.1080/21655979.2020.1843834

Figure 1.

Figure 1.

Scheme of PPARγ function and regulation of LEF1/phosphor-β-catenin and MMP2, MMP9 and calpain-2 in urothelial carcinoma. Rosiglitazone is PPARγ agonist, and GW9662 is PPARγ antagonist